Monday, December 23, 2024
HomeTagsTubulis

Tubulis

Tubulis Announces Strategic License Agreement with Bristol Myers Squibb to Develop Next Generation ADCs for the Treatment of Cancer Patients

Tubulis and Bristol Myers Squibb announced that they have entered into a strategic license agreement to develop differentiated antibody-drug conjugates (ADCs). Through the license agreement, Bristol Myers...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics